Historical record - last NADAC effective date: 10/19/2022
Product Information
DRY EYE RELIEF 0.3-0.4% DROP is a generic product labeled by Cardinal Health, priced at $0.6476 per ML under NDC 70000008801. Its NADAC has been published 74 times since May 18, 2022.
Strength
4; 3 mg/mL; mg/mL
Manufacturer
Cardinal HealthNDC
70000008801
Classification
Generic
Dosage Form
GEL
Route
OPHTHALMIC
Effective Date
10/19/2022
Active Ingredients
POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOLApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
3/9/2021
Price Statistics
The NADAC for DRY EYE RELIEF 0.3-0.4% DROP has been published 74 times since May 18, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6476 per ML |
|---|---|
| All-time high | $0.6526 (Oct 12, 2022) |
| All-time low | $0.6476 (Oct 19, 2022) |
| Median price | $0.6476 |
| Average price | $0.6491 |
| Largest weekly change | -0.8% (Oct 19, 2022) |
| Weeks tracked | 74 |
| Tracking since | May 18, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
N/A
All
-0.8%
Last surveyed Oct 11, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the polyethylene glycol and propylene glycol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
polyethylene glycol and propylene glycol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DRY EYE RELIEF 0.3-0.4% DROP?
The current National Average Drug Acquisition Cost (NADAC) for DRY EYE RELIEF 0.3-0.4% DROP, manufactured by Cardinal Health, is $0.6476 per ML (NDC 70000008801), effective Oct 11, 2023.
How has the price of DRY EYE RELIEF 0.3-0.4% DROP changed over time?
Over the history we have for it, the NADAC for DRY EYE RELIEF 0.3-0.4% DROP has held within roughly two percent of its current level. It has been tracked across 74 weekly CMS publications since May 18, 2022.
What are the highest and lowest recorded NADAC prices for DRY EYE RELIEF 0.3-0.4% DROP?
Since May 18, 2022, the NADAC for DRY EYE RELIEF 0.3-0.4% DROP has ranged from a low of $0.6476 (Oct 19, 2022) to a high of $0.6526 (Oct 12, 2022), with a median of $0.6476 per ML.
Are there cheaper alternatives to DRY EYE RELIEF 0.3-0.4% DROP?
No other NADAC-published product currently shares the active ingredient and strength of DRY EYE RELIEF 0.3-0.4% DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DRY EYE RELIEF 0.3-0.4% DROP?
DRY EYE RELIEF 0.3-0.4% DROP (NDC 70000008801) is labeled by Cardinal Health, and CMS classifies it as a generic product.